fbpx
Insight Conference
Chief Executive Officer

Amy Emerson

MAPS Public Benefit Corporation
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization. As the Chief Executive Officer, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC.
Amy started as a pro bono consultant at MAPS in 2003, and since then has built MAPS’ clinical department while managing the MDMA Clinical Development Program with a focus on the PTSD indication. In 2014, MAPS Public Benefit Corporation was incorporated to focus on psychedelic drug development, therapist training programs, and future sales of prescription psychedelics prioritizing public benefit above profit.

Events

After MDMA Approval – Outlook on Plans and Expected Developments

In my talk, I’ll discuss MAPS Public Benefit Corporation’s dru…

View Event
Round Table/ Panel VIII: A Glimpse of the Bigger Picture – Consciousness in Culture and Medicine

Moderated by: Dr. sc. hum. View Event

Insight Newsletter

Sign up to our newsletters and we’ll keep you up to date with everything to do with INSIGHT.




    Newsletter